- Home
- CLPT vs CAPR Comparison
CLPT vs CAPR Comparison
Compare CLPT & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPT
- CAPR
- Stock Information
- Founded
- CLPT 1998
- CAPR 2005
- Country
- CLPT United States
- CAPR United States
- Employees
- CLPT N/A
- CAPR N/A
- Industry
- CLPT Medical/Dental Instruments
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLPT Health Care
- CAPR Health Care
- Exchange
- CLPT Nasdaq
- CAPR Nasdaq
- Market Cap
- CLPT 355.7M
- CAPR 332.5M
- IPO Year
- CLPT N/A
- CAPR N/A
- Fundamental
- Price
- CLPT $12.14
- CAPR $19.67
- Analyst Decision
- CLPT Strong Buy
- CAPR Strong Buy
- Analyst Count
- CLPT 2
- CAPR 6
- Target Price
- CLPT $12.00
- CAPR $35.50
- AVG Volume (30 Days)
- CLPT 237.3K
- CAPR 1.9M
- Earning Date
- CLPT 11-07-2024
- CAPR 11-13-2024
- Dividend Yield
- CLPT N/A
- CAPR N/A
- EPS Growth
- CLPT N/A
- CAPR N/A
- EPS
- CLPT N/A
- CAPR N/A
- Revenue
- CLPT $28,069,000.00
- CAPR $27,152,218.00
- Revenue This Year
- CLPT $33.39
- CAPR N/A
- Revenue Next Year
- CLPT $24.44
- CAPR $135.53
- P/E Ratio
- CLPT N/A
- CAPR N/A
- Revenue Growth
- CLPT 29.33
- CAPR 187.15
- 52 Week Low
- CLPT $4.05
- CAPR $2.68
- 52 Week High
- CLPT $14.13
- CAPR $23.40
- Technical
- Relative Strength Index (RSI)
- CLPT 41.22
- CAPR 53.80
- Support Level
- CLPT $12.39
- CAPR $17.50
- Resistance Level
- CLPT $13.86
- CAPR $20.37
- Average True Range (ATR)
- CLPT 0.87
- CAPR 1.57
- MACD
- CLPT -0.10
- CAPR -0.73
- Stochastic Oscillator
- CLPT 33.57
- CAPR 24.91
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.